Moderna posts bigger loss than expected as it scales down manufacturing
Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to ...
Moderna remains the most shorted stock among S&P 500 healthcare stocks in the first month of 2025
Short interest for healthcare stocks in S&P 500 rose slightly in January vs. December, while Moderna continued to be the most ...
CWEB10h
Moderna, Inc. (NASDAQ:MRNA) Faces Challenges and Opportunities in Biotech Sector
Moderna’s consensus price target has significantly declined from $119.26 to $47.5, indicating a cautious outlook from ...
SoftBank reports new stakes in PacBio, Recursion Pharmaceuticals
SoftBank disclosed a 20.45M share position in PacBio (PACB) and 14.67M share position in Recursion Pharmaceuticals (RXRX) in a regulatory ...
Zacks Investment Research on MSN8h
Moderna Q4 Earnings and Revenues Beat, COVID Vaccine Sales Decline
Moderna MRNA incurred a loss of $2.50 per share in the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of ...
Early notable gainers among liquid option names on February 14th
Notable gainers among liquid option names this morning include Airbnb (ABNB) $160.54 +19.50, Wynn Resorts (WYNN) $87.64 +7.17, Super Micro ...